Quick search:
Content Search
Result Content Outlet Published Research
Result Content Outlet Published Research
1 IPF treatment, NXP002, Continues to Show Promise in Preclinical Studies Pulmonary Fibrosis News 21 hours ago
2 UCB : and Chiesi enter global license agreement for zampilimab a … 5 hours ago
3 Pulmonary Drugs Market Report 2021: COVID-19, Qualitative Analysis and Competitive Industry Scenario 2026 Northwest Diamond Notes 11 hours ago
4 Facing Outrageously Expensive Copays, I Turned to Foundations for Help Pulmonary Fibrosis News 7 days ago
5 Orphan Drugs Market Size is Projected To Reach USD 241610 Million By 2027 At A CAGR of 9.7% Valuates Reports 5 days ago
6 Idiopathic Pulmonary Fibrosis Disease Treatment Global Markets 2020-2024 3 months ago
7 Idiopathic Pulmonary Fibrosis Market Size anticipated to register growth at a CAGR of 16% during the forecast period [2020-2030] in the 7MM, estimates DelveInsight PRNewswire 10 months ago
8 Lung In Vitro Model Market Size, Competitors Strategy, Regional Analysis and Industry Growth by Forecast to EIN News 7 days ago
9 AdAlta : AGM presentations & first iCAR-T data 2 days ago
10 Economic and Market News for November 25 2021 Stock Market Wire 5 days ago
11 Small biotech chaired by ex-Purdue CEO Mark Timney jumps into the SPAC lane Endpoints News 20 days ago
12 FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer PRNewswire 21 days ago
13 Acute Respiratory Distress Syndrome (ARDS) Market Share, Size, Key Players, Trends, Competitive & Forecasts To EIN News 26 days ago
14 CohBar's CEO to Participate in Upcoming BIO Webinar 4 days ago
15 Plasma Therapy Market Worth $882.5 Million by 2028 Exclusive Report by Meticulous Research 14 days ago
16 Global Idiopathic Pulmonary Fibrosis Treatment Market Report 2020 GlobeNewswire 12 months ago
17 Idiopathic Pulmonary Fibrosis (IPF) Clinical Landscape Report 2021 with 10-Year Disease Incidence and Prevalence Forecasts GlobeNewswire 5 months ago
18 GlaxoSmithKline takes aim at NASH, penning a $1B pact with RNAi biotech Arrowhead FierceBiotech 8 days ago
19 Current and future players in the cystic fibrosis market Pharmaceutical Technology 3 months ago
20 CMS Issues COVID-19 Vaccine Mandate for Staff Across Health Care Facilities Drug Topics 15 days ago
21 Ceapro Inc. Announces R&D Funding to Support PGX Technology Project 22 hours ago
22 United Therapeutics (UTHR) Q3 Earnings & Sales Beat, Stock Up Nasdaq 26 days ago
23 Idiopathic Pulmonary Fibrosis: Exploring the Clinical and Economic Implications of the Evolving Treatment Landscape Managed Markets Network 7 months ago
24 Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Highlights GlobeNewswire 15 days ago
25 4 of the best portable nebulizer machines Medical News Today 6 days ago
26 Pliant's lung disease drug is getting where it needs to be, but efficacy data are still to come FierceBiotech 3 months ago
27 FDA OKs Clinical Trial Testing Cudetaxestat With Ofev, Esbriet Pulmonary Fibrosis News 3 months ago
28 Daewoong to develop pulmonary fibrosis drug to beat blockbuster Ofev Korea Biomedical Review 7 months ago
29 Researchers Ready New Treatment for IPF MD Magazine 9 months ago
30 FibroGen Reports Third Quarter 2021 Financial Results GlobeNewswire 21 days ago
31 The week in pharma: action, reaction and insight week to November 26 2 days ago
32 Krystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK™ in Patients with Dystrophic Epidermolysis Bullosa BioSpace 22 hours ago
33 The lung fibrosis pipeline thins Vantage 2 months ago
34 Pulmonary Drug Delivery Devices Market: Asthma Segment to Hold Largest Market Share BioSpace 3 months ago
35 Even with declining unemployment rate, plenty of jobs available in the Triangle right now WRAL Tech Wire 23 hours ago
36 Lung fibrosis in mice successfully reversed by scientists Drug Target Review 3 months ago
37 Taking an Alternative Approach to Drug Delivery Pharmaceutical Technology Magazine 28 days ago
38 FDA Designates Axatilimab an Orphan Drug for IPF Pulmonary Fibrosis News 8 months ago
39 Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis BioSpace 5 months ago
40 Dysregulated phospholipid metabolism leads to lung fibrosis | UIC Today UIC Today 1 month ago
41 Product launches forecast to propel systemic sclerosis market to $1.8 billion by 2030 The Pharma Letter 5 months ago
42 Ofev Costs to Treat PF-ILD Should Be Reimbursed in Canada, Groups Say Pulmonary Fibrosis News 9 months ago
43 COVID-19 Creating Growth Opportunities for Respiratory Drugs Market; Market to Cross USD 25500 million by GlobeNewswire 11 months ago
44 BioNews Clinical Will Bring Trials Into 'Continuum' of PF Care Pulmonary Fibrosis News 3 months ago
45 Moderna: Betting On A Valuable Pipeline Of New Therapies Seeking Alpha 2 days ago
46 FDA Clears Potential IPF Therapy, IM156, for Phase 1 Trial Pulmonary Fibrosis News 10 months ago
47 Aria Pharmaceuticals Presents Positive In Vivo Data Showing Two Novel Treatment Candidates Demonstrated Positive Efficacy and Tolerability in Idiopathic Pulmonary Fibrosis Compared to Standard of Care PRNewswire 3 months ago
48 Sarcoidosis Drug Market Global Sales are Expected to Grow GlobeNewswire 5 months ago
49 As Arrowhead falters, lungs remain a tough target for RNA drugs BioPharma Dive 5 months ago
50 FDA priority review for Roche's Esbriet in unclassifiable interstitial lung disease PMLiVE 10 months ago
51 Boston Biotech Vertex Struggles to Repeat Cystic Fibrosis Success Bloomberg 2 months ago
52 IM156 on Fast Track as IPF Treatment Pulmonary Fibrosis News 7 months ago
53 Palatin Technologies (PTN) Stock Price Surged 33.7% Premarket Despite Lack of News AskTraders 20 hours ago
54 US Patent Awaited for Nuformix's Potential IPF Inhalation Therapy Pulmonary Fibrosis News 6 months ago
55 Vicore To Host Key Opinion Leader Webinar On C21 For The Treatment of Idiopathic Pulmonary Fibrosis (IPF) Yahoo Finance 2 months ago
56 Algernon Pharmaceuticals Announces 50% Enrollment of its GlobeNewswire 7 months ago
57 Humans Harness AI To Speed Drug Development WebMD 5 months ago
58 Exceptionally Robust Asthma Pipeline with More Than 100+ GlobeNewswire 1 month ago
59 Precision Medicine Market Size & Share 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research Yahoo Finance 2 months ago
60 Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis Business Wire 1 month ago
61 Mayo Clinic Researchers Publish Critical Study: Antifibrotics Can Extend Lives for IPF Patients Chicago Daily Herald 4 months ago
62 Novel model developed to resemble aberrant IPF lung epithelium Drug Target Review 3 months ago
63 Lunit raises $61M, prepares for South Korean listing BioWorld Online 12 hours ago
64 Microgel coating gives donor cells a boost in reversing pulmonary fibrosis | UIC Today UIC Today 6 months ago
65 United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis BioSpace 12 months ago
66 Meniere's Disease Pipeline Research Report 2021: Comprehensive Insights About 10+ Companies and 10+ Pipeline Drugs 5 days ago
67 Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF) Business Wire 6 months ago
68 Glenmark gets USFDA nod for generic lung cancer drug Economic Times 5 months ago
69 Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis(IPF) shows promising result in early stage clinical test PRNewswire 6 months ago
70 NeRRe nabs £20M to test chronic cough drug in patients with a fatal lung disease MedCity News 5 months ago
71 Five Collaborations Unlocking Faster Drug Development this Week BioSpace 6 months ago
72 Systemic Sclerosis Global Drug Forecast and Market Analysis to 2030 6 months ago
73 Esbriet (Pirfenidone): An Oral Anti-fibrotic Medicine Approved for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) GlobeNewswire 11 months ago
74 Insmed Incorporated: Some Rare Insider Buying Noted Seeking Alpha 20 days ago
75 Improving Outcomes and Managing Costs in Idiopathic Pulmonary Fibrosis Managed Markets Network 2 years ago
76 Tyvaso DPI for PH-ILD Earns FDA's Priority Review Status Pulmonary Fibrosis News 6 months ago
77 Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine PR Newswire India 4 months ago
78 Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to its Board of Directors and the Expansion of its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical Development Business Wire 2 months ago
79 Pulmonary Drug Delivery Devices Market Research Report by GlobeNewswire 4 months ago
80 United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis PRNewswire 6 months ago
81 Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update PRNewswire 21 days ago
82 Sanofi-Regeneron find narrower population of former smokers for COPD drug after midstage trial fails overall goal FierceBiotech 4 months ago
83 Cipla gets CDSCO panel nod for BE study of idiopathic pulmonary fibrosis drug Pirfenidone Medical Dialogues 3 months ago
84 PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders Business Wire 7 months ago
85 US stocks perform well overall but the Dow lags behind Proactive Investors USA & Canada 6 days ago
86 SignalRx, Crystec and ADYA Partner to Develop Treatment for SARS-CoV-2 Related Illnesses Contract Pharma 3 months ago
87 Idiopathic Pulmonary Fibrosis (IPF) Clinical Report 2021: Treatment, Epidemiology, Marketed & Pipeline Drugs, Deals, Revenue Opportunities PRNewswire 5 months ago
88 Boehringer Ingelheim lines up celebrity judges for songwriting contest in lung disease awareness campaign FiercePharma 7 months ago
89 Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline Vantage 12 months ago
90 Bridge Biotherapeutics to keep developing rare lung disease drug in US Korea Biomedical Review 5 months ago
91 Study analysis available during ATS 2021 supports long-term treatment with Ofev® in patients with systemic sclerosis-associated interstitial lung disease PRNewswire 7 months ago
92 Inhaled GB0139 for IPF Named Orphan Drug in US and EU Pulmonary Fibrosis News 1 year ago
93 Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF) Yahoo Finance 2 months ago
94 Tyvaso (inhaled treprostinil) Pulmonary Fibrosis News 7 months ago
95 Ofev Effective in Elderly Patients, Those With Comorbidities Pulmonary Fibrosis News 7 months ago
96 Galapagos and Gilead to end late-stage studies of lung disease drug Reuters 10 months ago
97 Avalyn Pharma touts study of aerosolized pulmonary fibrosis treatment Mass Device 6 months ago
98 MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery Business Wire 9 months ago
99 AI drug discovery platform Insilico Medicine announces $255 million in Series C funding TechCrunch 5 months ago
100 Galapagos NV: Value Play, Or Value Trap? Sick Economics 4 months ago